Harbour Investments Inc. Sells 66 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Harbour Investments Inc. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 19.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 281 shares of the company’s stock after selling 66 shares during the period. Harbour Investments Inc.’s holdings in HCA Healthcare were worth $84,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $36,000. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare during the third quarter valued at approximately $39,000. Activest Wealth Management increased its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. lifted its position in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA stock opened at $329.25 on Monday. The stock has a 50-day moving average price of $321.50 and a 200-day moving average price of $342.71. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm has a market cap of $81.06 billion, a PE ratio of 14.99, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the business posted $5.90 earnings per share. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is 13.11%.

Analyst Ratings Changes

A number of research firms have recently commented on HCA. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Bank of America lowered their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Royal Bank of Canada reduced their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. Barclays cut their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Finally, Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.